Pre-tax profit of €573m for UCB – Irish Independent

by admin on January 8, 2013

Pre-tax profit of €573m for UCB
Irish Independent
continued to grow in 2011 with an overall increase of 11pc to over €90m due mainly to continued growth of Neupro in new and existing markets." Neurpo is used to treat Parkinson's disease and Restless Leg Syndrome. – Gordon Deegan. Irish Independent

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: